2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane

C108H175F3N18O — CID 158051580

IUPAC2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane
SMILESCC(C)(C)N1CCC2(CCC(OCCn3ccnc3)CC2)CC1.CC(C)(C)N1CCC2(CCC(c3cccnc3)CC2)C1.CC(C)(C)N1CCC2(CCC(n3ccnc3)CC2)CC1.CC(C)(C)N1CCC2(CCN(c3ncc(C(F)(F)F)cn3)CC2)C1.Cc1cc(N2CCC3(CC2)CCN(C(C)(C)C)C3)cc(C)n1.Cc1cc(N2CCC3(CC2)CCN(C(C)(C)C)C3)ccn1
InChIInChI=1S/C19H33N3O.C19H31N3.C18H29N3.C18H28N2.C17H25F3N4.C17H29N3/c1-18(2,3)22-11-8-19(9-12-22)6-4-17(5-7-19)23-15-14-21-13-10-20-16-21;1-15-12-17(13-16(2)20-15)21-9-6-19(7-10-21)8-11-22(14-19)18(3,4)5;1-15-13-16(5-9-19-15)20-10-6-18(7-11-20)8-12-21(14-18)17(2,3)4;1-17(2,3)20-12-10-18(14-20)8-6-15(7-9-18)16-5-4-11-19-13-16;1-15(2,3)24-9-6-16(12-24)4-7-23(8-5-16)14-21-10-13(11-22-14)17(18,19)20;1-16(2,3)20-11-8-17(9-12-20)6-4-15(5-7-17)19-13-10-18-14-19/h10,13,16-17H,4-9,11-12,14-15H2,1-3H3;12-13H,6-11,14H2,1-5H3;5,9,13H,6-8,10-12,14H2,1-4H3;4-5,11,13,15H,6-10,12,14H2,1-3H3;10-11H,4-9,12H2,1-3H3;10,13-15H,4-9,11-12H2,1-3H3
InChIKeyFJNYSOCJRVPGDI-UHFFFAOYSA-N
MW1798.71 g/mol
LogP22.69
Rot. Bonds9

About 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane

2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane (PubChem CID 158051580) has the molecular formula C108H175F3N18O and a molecular weight of 1798.71 g/mol. Its IUPAC name is 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane.

Molecular Properties

Compound Name2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane
PubChem CID158051580
Molecular FormulaC108H175F3N18O
Molecular Weight1798.71 g/mol
Exact Mass1797.41
IUPAC Name2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane
SMILESCC(C)(C)N1CCC2(CCC(OCCn3ccnc3)CC2)CC1.CC(C)(C)N1CCC2(CCC(c3cccnc3)CC2)C1.CC(C)(C)N1CCC2(CCC(n3ccnc3)CC2)CC1.CC(C)(C)N1CCC2(CCN(c3ncc(C(F)(F)F)cn3)CC2)C1.Cc1cc(N2CCC3(CC2)CCN(C(C)(C)C)C3)cc(C)n1.Cc1cc(N2CCC3(CC2)CCN(C(C)(C)C)C3)ccn1
InChIInChI=1S/C19H33N3O.C19H31N3.C18H29N3.C18H28N2.C17H25F3N4.C17H29N3/c1-18(2,3)22-11-8-19(9-12-22)6-4-17(5-7-19)23-15-14-21-13-10-20-16-21;1-15-12-17(13-16(2)20-15)21-9-6-19(7-10-21)8-11-22(14-19)18(3,4)5;1-15-13-16(5-9-19-15)20-10-6-18(7-11-20)8-12-21(14-18)17(2,3)4;1-17(2,3)20-12-10-18(14-20)8-6-15(7-9-18)16-5-4-11-19-13-16;1-15(2,3)24-9-6-16(12-24)4-7-23(8-5-16)14-21-10-13(11-22-14)17(18,19)20;1-16(2,3)20-11-8-17(9-12-20)6-4-15(5-7-17)19-13-10-18-14-19/h10,13,16-17H,4-9,11-12,14-15H2,1-3H3;12-13H,6-11,14H2,1-5H3;5,9,13H,6-8,10-12,14H2,1-4H3;4-5,11,13,15H,6-10,12,14H2,1-3H3;10-11H,4-9,12H2,1-3H3;10,13-15H,4-9,11-12H2,1-3H3
InChIKeyFJNYSOCJRVPGDI-UHFFFAOYSA-N
XLogP22.69
TPSA138.48 Ų
H-Bond Donors
H-Bond Acceptors19
Rotatable Bonds9
Heavy Atoms130
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001798.71
LogP ≤ 522.69
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1019

Analyze 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-[6-[[1-[5-[[7-[4-(4-chloro-1-methylimidazol-2-yl)phenyl]-1-(2-propan-2-yl-3-pyridinyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-3-yl]methyl]-2-propan-2-yl-3-pyridinyl]-7-[4-[1-(2-methoxyethyl)pyrazol-4-yl]phenyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-3-yl]methyl]-2-propan-2-yl-3-pyridinyl]-3,5-dimethyl-7-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine
CID 154970495
(8S)-3,8-dimethyl-1-[6-[[(8R)-8-methyl-1-[6-[[8-methyl-7-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]-1-(2-propan-2-yl-3-pyridinyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-3-yl]methyl]-2-propan-2-yl-3-pyridinyl]-7-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazin-3-yl]methyl]-2-propan-2-yl-3-pyridinyl]-7-[5-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]-2-pyridinyl]-6,8-dihydro-5H-imidazo[1,5-a]pyrazine
CID 154970541
7-(4,4-Difluoropiperidin-1-yl)-3-(3,5-dimethylimidazol-4-yl)-5-[(3-fluoro-2-pyridinyl)-(oxan-4-yl)methyl]pyrido[3,2-b]indole
CID 157070982
9-[[3,5-Difluoro-4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-7-methyl-2-(2-propan-2-yl-3-pyridinyl)purin-8-one;9-[[3-fluoro-4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-7-methyl-2-(2-propan-2-yl-3-pyridinyl)purin-8-one;methane;7-methyl-9-[[4-[1-(oxetan-3-yl)-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-2-(2-propan-2-yl-3-pyridinyl)purin-8-one
CID 157615684
3-Tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;9-tert-butyl-3-pyridin-4-yl-3,9-diazaspiro[5.6]dodecane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane
CID 157772929
(1R,5S)-3-ethyl-6-[2-ethyl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-azabicyclo[3.1.0]hexane;(1R,5S)-6-[2-ethyl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-(2-fluoroethyl)-3-azabicyclo[3.1.0]hexane;(1R,5S)-3-(2-fluoroethyl)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-azabicyclo[3.1.0]hexane;(1R,5S)-3-(2-fluoroethyl)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-2-pentan-3-ylimidazol-1-yl]-3-azabicyclo[3.1.0]hexane;tris(4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-2-propan-2-ylimidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]morpholine)
CID 158051648
3-Methyl-5-[1-(6-morpholin-4-ylspiro[3.3]heptan-2-yl)-2-propan-2-ylimidazol-4-yl]pyridin-2-amine;2-methyl-5-[1-[2-(oxan-4-yl)ethyl]-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;2-methyl-5-[1-(oxan-4-ylmethyl)-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;2-methyl-5-[1-[1-(oxetan-3-yl)pyrrolidin-3-yl]-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;4-[3-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-2-propan-2-ylimidazol-1-yl]cyclobutyl]morpholine;4-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-2-propan-2-ylimidazol-1-yl]cyclohexan-1-ol;4-[2-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-2-propan-2-ylimidazol-1-yl]spiro[3.3]heptan-6-yl]morpholine
CID 158391324
5-(1-Cyclopentyl-2-propan-2-ylimidazol-4-yl)-2-methyl-3-(trifluoromethyl)pyridine;5-[1-(3,3-difluorocyclobutyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;2-methyl-5-[1-[1-(oxetan-3-yl)azetidin-3-yl]-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;2-methyl-5-[1-(oxetan-3-yl)-2-propan-2-ylimidazol-4-yl]-3-(trifluoromethyl)pyridine;2-methyl-5-[2-propan-2-yl-1-(pyridin-2-ylmethyl)imidazol-4-yl]-3-(trifluoromethyl)pyridine;2-methyl-5-[2-propan-2-yl-1-(pyridin-3-ylmethyl)imidazol-4-yl]-3-(trifluoromethyl)pyridine;6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-2-propan-2-ylimidazol-1-yl]-2-(oxetan-3-yl)-2-azaspiro[3.3]heptane
CID 158481243
7-(4,4-difluoropiperidin-1-yl)-3-(3,5-dimethylimidazol-4-yl)-6-fluoro-5-[(S)-(3-fluoro-2-pyridinyl)-(oxan-4-yl)methyl]pyrido[3,2-b]indole;7-(4,4-difluoropiperidin-1-yl)-3-(3,5-dimethylimidazol-4-yl)-6-fluoro-5-[(S)-oxan-4-yl(phenyl)methyl]pyrido[3,2-b]indole
CID 158580326
6,6-dimethyl-2-(2-methylpyrimidin-5-yl)-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazine;4-[6,6-dimethyl-2-[6-methyl-4-(trifluoromethyl)-3-pyridinyl]-8,9-dihydro-7H-purino[9,8-a]pyridin-4-yl]morpholine;2-(2,4-dimethylpyrimidin-5-yl)-6,6-dimethyl-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazine;2-(2-methylpyrimidin-5-yl)-4-morpholin-4-yl-8,9-dihydro-7H-purino[8,9-b][1,3]oxazine;4-[2-(2-methylpyrimidin-5-yl)-6,7,8,9-tetrahydropurino[9,8-a]pyridin-4-yl]morpholine
CID 158585604
bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-(2-fluoroethyl)piperazine);bis(1-[(1S,5R)-6-[2-(cyclopropylmethyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]-4-methylpiperazine);1-(2-fluoroethyl)-4-[(1R,5S)-6-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-3-bicyclo[3.1.0]hexanyl]piperazine;methane;4-[(1S,5R)-6-[4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]-1-propan-2-ylimidazol-2-yl]-3-bicyclo[3.1.0]hexanyl]morpholine
CID 158617093
1-(2-Fluorophenyl)-4-[1-methyl-4-[3-(trifluoromethyl)phenyl]imidazol-2-yl]piperazine;1-(5-methyl-2-pyridinyl)-4-[1-methyl-4-[3-(trifluoromethyl)phenyl]imidazol-2-yl]piperazine;1-(6-methyl-2-pyridinyl)-4-[1-methyl-4-[3-(trifluoromethyl)phenyl]imidazol-2-yl]piperazine;5-[4-[1-methyl-4-[3-(trifluoromethyl)phenyl]imidazol-2-yl]piperazin-1-yl]pyrimidine;1-[1-methyl-4-[3-(trifluoromethyl)phenyl]imidazol-2-yl]-4-[3-(trifluoromethyl)-2-pyridinyl]piperazine
CID 158670869

Frequently Asked Questions

What is the IUPAC name of 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane?
The IUPAC name of 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane (CID 158051580) is 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane.
What is the SMILES notation for 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane?
The canonical SMILES for 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane is CC(C)(C)N1CCC2(CCC(OCCn3ccnc3)CC2)CC1.CC(C)(C)N1CCC2(CCC(c3cccnc3)CC2)C1.CC(C)(C)N1CCC2(CCC(n3ccnc3)CC2)CC1.CC(C)(C)N1CCC2(CCN(c3ncc(C(F)(F)F)cn3)CC2)C1.Cc1cc(N2CCC3(CC2)CCN(C(C)(C)C)C3)cc(C)n1.Cc1cc(N2CCC3(CC2)CCN(C(C)(C)C)C3)ccn1.
What is the InChIKey of 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane?
The InChIKey is FJNYSOCJRVPGDI-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H33N3O.C19H31N3.C18H29N3.C18H28N2.C17H25F3N4.C17H29N3/c1-18(2,3)22-11-8-19(9-12-22)6-4-17(5-7-19)23-15-14-21-13-10-20-16-21;1-15-12-17(13-16(2)20-15)21-9-6-19(7-10-21)8-11-22(14-19)18(3,4)5;1-15-13-16(5-9-19-15)20-10-6-18(7-11-20)8-12-21(14-18)17(2,3)4;1-17(2,3)20-12-10-18(14-20)8-6-15(7-9-18)16-5-4-11-19-13-16;1-15(2,3)24-9-6-16(12-24)4-7-23(8-5-16)14-21-10-13(11-22-14)17(18,19)20;1-16(2,3)20-11-8-17(9-12-20)6-4-15(5-7-17)19-13-10-18-14-19/h10,13,16-17H,4-9,11-12,14-15H2,1-3H3;12-13H,6-11,14H2,1-5H3;5,9,13H,6-8,10-12,14H2,1-4H3;4-5,11,13,15H,6-10,12,14H2,1-3H3;10-11H,4-9,12H2,1-3H3;10,13-15H,4-9,11-12H2,1-3H3.
What are the key properties of 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane?
2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane has a molecular weight of 1798.71 g/mol, XLogP of 22.69, 9 rotatable bonds, 0 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for 2-tert-butyl-8-(2,6-dimethyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;3-tert-butyl-9-imidazol-1-yl-3-azaspiro[5.5]undecane;3-tert-butyl-9-(2-imidazol-1-ylethoxy)-3-azaspiro[5.5]undecane;2-tert-butyl-8-(2-methyl-4-pyridinyl)-2,8-diazaspiro[4.5]decane;2-tert-butyl-8-pyridin-3-yl-2-azaspiro[4.5]decane;2-tert-butyl-8-[5-(trifluoromethyl)pyrimidin-2-yl]-2,8-diazaspiro[4.5]decane is sourced from PubChem (CID 158051580), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).